Levin Capital Strategies, L.P.
Source: SEC Form 13F · as of Mar 2026Levin Capital Strategies, L.P. holds 15 biotech & pharma companies tracked by BioSniper, totaling $100.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
15
Total value held
$100.7M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 207,248 | $50.7M |
| VTRSViatris Inc | 1,039,633 | $14.0M |
| ABBVAbbVie Inc. | 42,022 | $9.1M |
| GMOptec International, Inc. | 110,114 | $8.2M |
| AURAAura Biosciences, Inc. | 941,400 | $6.3M |
| SPRYARS Pharmaceuticals, Inc. | 552,561 | $4.4M |
| ZTSZoetis Inc. | 20,013 | $2.4M |
| DGXQuest Diagnostics Incorporated | 8,500 | $1.7M |
| MRKMerck & Co., Inc. | 13,322 | $1.6M |
| DRTSAlpha Tau Medical Ltd. | 106,423 | $752K |
| SMMTSummit Therapeutics Inc. | 37,676 | $714K |
| FLGTFulgent Genetics Inc. | 43,234 | $687K |
| IMRXImmuneering Corp | 10,000 | $53K |
| PRMEPrime Medicine, Inc. | 15,000 | $52K |
| ALLOAllogene Therapeutics, Inc. | 13,125 | $32K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.